Barclays PLC Covetrus, Inc. Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 03, 2022
BUY
$20.69 - $20.91 $2.66 Million - $2.69 Million
128,481 Added 149.85%
214,220 $4.47 Million
Q2 2022

Aug 12, 2022
SELL
$13.8 - $20.82 $677,690 - $1.02 Million
-49,108 Reduced 36.42%
85,739 $1.78 Million
Q1 2022

May 16, 2022
SELL
$15.96 - $18.87 $614,188 - $726,174
-38,483 Reduced 22.2%
134,847 $2.26 Million
Q4 2021

Feb 14, 2022
BUY
$16.79 - $20.37 $1.09 Million - $1.33 Million
65,214 Added 60.32%
173,330 $3.46 Million
Q3 2021

Nov 09, 2021
BUY
$18.14 - $27.03 $815,048 - $1.21 Million
44,931 Added 71.11%
108,116 $1.96 Million
Q2 2021

Aug 13, 2021
SELL
$25.24 - $30.86 $2.15 Million - $2.62 Million
-85,040 Reduced 57.37%
63,185 $1.71 Million
Q1 2021

May 13, 2021
SELL
$28.29 - $39.89 $310,058 - $437,194
-10,960 Reduced 6.89%
148,225 $4.44 Million
Q4 2020

Feb 11, 2021
SELL
$24.45 - $31.59 $325,160 - $420,115
-13,299 Reduced 7.71%
159,185 $4.57 Million
Q3 2020

Nov 12, 2020
BUY
$17.22 - $24.59 $1.01 Million - $1.44 Million
58,511 Added 51.34%
172,484 $4.21 Million
Q2 2020

Aug 12, 2020
SELL
$6.46 - $19.27 $572,155 - $1.71 Million
-88,569 Reduced 43.73%
113,973 $2.04 Million
Q1 2020

May 13, 2020
SELL
$5.64 - $15.23 $125,963 - $340,146
-22,334 Reduced 9.93%
202,542 $1.65 Million
Q4 2019

Feb 10, 2020
BUY
$8.8 - $14.93 $1.58 Million - $2.68 Million
179,782 Added 398.68%
224,876 $2.97 Million
Q3 2019

Nov 14, 2019
SELL
$11.76 - $25.57 $161,253 - $350,615
-13,712 Reduced 23.32%
45,094 $535,000
Q2 2019

Aug 14, 2019
BUY
$22.88 - $33.27 $592,157 - $861,060
25,881 Added 78.61%
58,806 $1.44 Million
Q1 2019

May 15, 2019
BUY
$31.52 - $46.19 $1.04 Million - $1.52 Million
32,925 New
32,925 $1.05 Million

Others Institutions Holding CVET

# of Institutions
8
Shares Held
72.9K
Call Options Held
0
Put Options Held
0
View Full List

About COVETRUS, INC.

CVET Quotes by TradingView
  • Ticker CVET
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 140,123,008
  • Description
  • Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vacc...
More about CVET
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email